Medical/Pharmaceuticals
2023 Brain Health and Disability Webinar: Leave No One Behind
LONDON, July 20, 2023 /PRNewswire/ -- This year marks the 10th Anniversary of World Brain Day, hosted annually onJuly 22 by the World Federation of Neurology (WFN). This year's World Brain Day will bring together expert neurologists, advocates and patients to share vital resources and information...
BioCity announces the first patient dosed with its first-in-class CDH3-targeting ADC BC3195 in a Phase 1 Trial
WUXI, China, July 19, 2023 /PRNewswire/ -- BioCity Biopharma, a clinical-stage biopharmaceutical company committed to developing novel and highly differentiated, modality-independent therapeutics for cancer and autoimmune disorders, today announced the dosing of the first patient in a Phase 1a/1b...
Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech
ZHUHAI, China, July 19, 2023 /PRNewswire/ -- Biotheus Inc. ("Biotheus"), a clinical-stage biotech company dedicated to the discovery and development of biologics for oncology and inflammatory diseases, announced today that it has entered into a strategic research collaboration, option and worldwi...
Gannex Announces the Completion of Patient Enrollment for Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis
-- Gannex is expected to release topline data of the Phase II clinical trial by the end of 2023 SHANGHAI, July 20, 2023 /PRNewswire/ -- Gannex Pharma Co., Ltd. ("Gannex"), a wholly-owned company of Ascletis Pharma Inc. (HKEX:1672) announces today the completion of enrollment of 98 patients with ...
Harrison.ai Welcomes Robyn Denholm As Board Director
SYDNEY, July 20, 2023 /PRNewswire/ -- Global technology leader Robyn Denholm
has been announced as the newest member of theHarrison.ai
VARON Launches the Game-changer in the Field--New VP Series Portable Oxygen Concentrator with Increased Mobility and Convenience
SEATTLE, July 19, 2023 /PRNewswire/ -- VARON, a leading oxygen concentrator
Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA
SUZHOU, China, July 19, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has initiated the long-term safety trial (the "Long-term ...
SIMPLE FINGER PRICK TEST EXEMPLIFIES ADVANCES IN ALZHEIMER'S DISEASE BLOOD TESTS
Key Takeaways: * Results from a simple, finger prick blood test are promising and may help detect Alzheimer's at home or in the doctor's office. * A blood test was more than 80% accurate in identifying Alzheimer's-related changes — significantly better than doctors in the study who did not ha...
Significantly Reduce Manufacturing Cost and Increased Local Production: SCG Cell Therapy Opens State-of-the-art Cell Therapy Manufacturing Facility and R&D Centre in Singapore
* SCG Cell Therapy celebrates the opening of its new Cell Therapy Manufacturing Facility and R&D Centre, launching a new first-of-its-kind automatic cell therapy manufacturing system in Singapore, pioneeringSingapore's Manufacturing 2030 Vision. * Facility will substantially increase local ...
GHA Accreditation Helps Position Dr. Sulaiman Al-Habib Hospital in Al Khobar as a Trusted Destination for Medical Travel
PALM BEACH GARDENS, Fla., July 19, 2023 /PRNewswire/ -- In a significant achievement that firmly underscores its commitment to the highest standards of healthcare, Dr. Sulaiman AL-Habib Hospital in AL Khobar, Saudi Arabia, has been awarded the distinguished Accreditation for Medical Travel Servic...
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow
MELBOURNE, Australia, July 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended30 June 2023 (Q2 2023). All figures are in AUD$ unless otherwise stated[...
The International Conference on Pharmaceutical Innovation and Development 2023 Kicked off in Yantai
YANTAI, China, July 19, 2023 /PRNewswire/ -- On the morning of July 13, the International Conference on Pharmaceutical Innovation and Development 2023 kicked off in Yantai. The conference was hosted by the People's Government of Shandong Province, co-sponsored by the Chinese Pharmaceutical Associa...
Philips Foundation partners with World Heart Federation to provide half a million children at risk of rheumatic heart disease with access to life-saving early detection
The partnership aims to curb the high prevalence and mortality rates due to rheumatic heart disease in underserved communities ofAsia Pacific, starting with the Philippines, a high-burden country. AMSTERDAM, July 19, 2023 /PRNewswire/ -- Philips Foundation, with its mission to provide access t...
BioWorld by Clarivate Recognized for Excellence in Publishing
Suite of news services receives four 2023 APEX Awards for Publications Excellence LONDON, July 19, 2023 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, is the winn...
Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication
SHANGHAI , July 18, 2023 /PRNewswire/ -- The product of Fosun Kite Biotechnology Co., Ltd., jointly established by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Kite Pharma ofthe United States (trade name: Yikaida®) for the treatment of adult large B-cell lymphoma (r/r LBCL) ("this new ind...
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet
SEOUL, South Korea, July 19, 2023 /PRNewswire/ -- Daewoong Pharmaceutical obtained approval for a SGLT-2 inhibitor+metformin combination drug in just one month after the release of Envlo Tab., the 1st SGLT-2 inhibitor by Korea, expanding its product portfolio. Daewoong Pharmaceutical (Jeon Sen...
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib
MELBOURNE, Australia, July 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Company's investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstad...
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND
SHANGHAI, July 18, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 9MW2921 for advanced solid tumor was approved by the National Medical Products Administration (NMPA). 9MW2921 is dev...
Neurophet to unveil brain image analysis technology related to treatment of Alzheimer's disease at AAIC 2023
- New brain image analysis solution for Alzheimer's disease treatment is planned to be commercialized along with the release of treatment - In discussion with global big pharma companies for collaboration at AAIC SEOUL, South Korea, July 18, 2023 /PRNewswire/ -- Neurophet, an artificial in...
Baird Medical Obtains NMPA Approval of Class III Registered Microwave Ablation Needle for Thyroid Nodules
GUANGZHOU, China, July 18, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, announced today that the Company's independently developed and produced disposable MWA ...
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 349 media titles]
2024-12-10 10:00Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:076th HIIFF Closes with Golden Coconut Award Ceremony
[Picked up by 282 media titles]
2024-12-11 22:19